Moxifloxacin Stulln

Moxifloxacin, the active ingredient in Moxifloxacin Stulln, is a fluoroquinolone antibiotic presented as an ophthalmic solution for ocular use. It treats bacterial eye infections such as conjunctivitis and keratitis in adults and children.

GNH USA supplies Moxifloxacin Stulln as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacin is a fluoroquinolone antibiotic used to treat bacterial infections of the eye.

- Bacterial conjunctivitis: reduces bacterial load and resolves redness, discharge and irritation. - Bacterial keratitis: eradicates pathogenic bacteria, promoting corneal healing and visual recovery. - Post‑operative ocular prophylaxis: prevents infection after cataract or refractive surgery.

Moxifloxacin eye drops may cause local ocular reactions.

Common Side Effects: - Eye irritation or burning sensation. - Redness of the conjunctiva. - Increased tearing. - Foreign body sensation. - Temporary blurred vision. - Mild eyelid swelling.

Serious or Rare Side Effects: - Allergic reaction (e.g., swelling, rash, itching). - Severe eye pain or corneal ulceration. - Vision loss. - Anaphylaxis. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Persistent intraocular inflammation.

Moxifloxacin should be used with caution and under professional supervision.

- Hypersensitivity: avoid if the patient has known allergy to fluoroquinolones. - Viral eye infections: do not use for viral conjunctivitis or keratitis. - Corneal epithelial defects: monitor closely as irritation may be heightened. - Concomitant corticosteroid drops: may mask signs of infection. - Contact lens wear: discontinue lens use during treatment. - Store at room temperature: keep in the original container, protect from light and moisture.

Moxifloxacin eye drops have limited systemic interactions, but caution is advised.

Major Interactions (Avoid): - Systemic fluoroquinolones: concurrent use may increase risk of tendon toxicity. - Corticosteroid eye drops: can mask infection signs and delay healing. - Anticholinergic ophthalmic agents: may reduce drug absorption.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory eye drops: may increase ocular irritation. - Preservative‑containing contact lens solutions: could affect drug stability. - Herbal supplements with quinine: potential additive fluoroquinolone effect.